TY - JOUR
T1 - Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells
AU - Riemekasten, Gabriela
AU - Langnickel, Dirk
AU - Enghard, Philipp
AU - Undeutsch, Reinmar
AU - Humrich, Jens
AU - Ebling, Fanny M.
AU - Hocher, Berthold
AU - Humaljoki, Tiina
AU - Neumayer, Hans
AU - Burmester, Gerd R.
AU - Hahn, Bevra H.
AU - Radbruch, Andreas
AU - Hiepe, Falk
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2004/11/1
Y1 - 2004/11/1
N2 - T cells that recognize nucleoproteins are required for the production of anti-dsDNA Abs involved in lupus development. SmD183-119(a D1 protein of the Smith (Sm) proteins, part of small nuclear ribonucleoprotein) was recently shown to provide T cell help to anti-dsDNA Abs in the NZB/NZW model of lupus. Using this model in the present study, we showed that high dose tolerance to SmD1 (600-1000 μg i.v. of SmD183-119peptide/mo) delays the production of autoantibodies, postpones the onset of lupus nephritis as confirmed by histology, and prolongs survival. Tolerance to SmD1 83-119 was adoptively transferred by CD90+ T cells, which also reduce T cell help for autoreactive B cells in vitro. One week after SmD183-119 tolerance induction in prenephritic mice, we detected cytokine changes in cultures of CD90+ T and B22O+ B cells with decreased IFN-γ and IL-4 expression and an increase in TGFβ. Increased frequencies of regulatory IFN-γ+ and IL10+ CD4+ T cells were later detected. Such regulatory IL-10 +/IFN-γ+ type 1 regulatory T cells prevented autoantibody generation and anti-CD3-induced proliferation of naive T cells. In conclusion, these results indicate that SmD183-119 peptide may play a dominant role in the activation of helper and regulatory T cells that influence autoantibody generation and murine lupus.
AB - T cells that recognize nucleoproteins are required for the production of anti-dsDNA Abs involved in lupus development. SmD183-119(a D1 protein of the Smith (Sm) proteins, part of small nuclear ribonucleoprotein) was recently shown to provide T cell help to anti-dsDNA Abs in the NZB/NZW model of lupus. Using this model in the present study, we showed that high dose tolerance to SmD1 (600-1000 μg i.v. of SmD183-119peptide/mo) delays the production of autoantibodies, postpones the onset of lupus nephritis as confirmed by histology, and prolongs survival. Tolerance to SmD1 83-119 was adoptively transferred by CD90+ T cells, which also reduce T cell help for autoreactive B cells in vitro. One week after SmD183-119 tolerance induction in prenephritic mice, we detected cytokine changes in cultures of CD90+ T and B22O+ B cells with decreased IFN-γ and IL-4 expression and an increase in TGFβ. Increased frequencies of regulatory IFN-γ+ and IL10+ CD4+ T cells were later detected. Such regulatory IL-10 +/IFN-γ+ type 1 regulatory T cells prevented autoantibody generation and anti-CD3-induced proliferation of naive T cells. In conclusion, these results indicate that SmD183-119 peptide may play a dominant role in the activation of helper and regulatory T cells that influence autoantibody generation and murine lupus.
UR - http://www.scopus.com/inward/record.url?scp=6344268942&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.173.9.5835
DO - 10.4049/jimmunol.173.9.5835
M3 - Journal articles
C2 - 15494537
AN - SCOPUS:6344268942
SN - 0022-1767
VL - 173
SP - 5835
EP - 5842
JO - Journal of Immunology
JF - Journal of Immunology
IS - 9
ER -